Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 5OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

MSS Metastatic Colorectal Cancer 1

Interventions

Exercise 16Standard of Care 10Control Groups 9Surgical Procedures, Operative 8Radiotherapy, Intensity-Modulated 6Radiotherapy 6Endoscopic Mucosal Resection 6Drug Therapy 6Blood Specimen Collection 6Indocyanine Green 5apatinib 4anlotinib 4Metformin 4Magnetic Resonance Spectroscopy 4Laparoscopy 4Fluorouracil 4Cisplatin 4camrelizumab 3Vitamin D 3Ultrasonography 3Therapeutics 3Sentinel Lymph Node Biopsy 3Saline Solution 3Radiofrequency Ablation 3Quality of Life 3Proton Therapy 3Preoperative Exercise 3Methylene Blue 3Mammography 3Magnetic Resonance Imaging 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × OTHER_GOV × HMPL-013 × Clear all
NCT06613113 2024-09-25

Fruquintinib Combined With Adebrelimab and High and Low Dose Radiotherapy in the Treatment of Second-line and Above Failure MSS Metastatic Colorectal Cancer.

Ningbo Medical Center Lihuili Hospital

Phase NA Recruiting
30 enrolled
Gastrointestinal

MSS Metastatic Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡